Skip to main content
OGN $13.72 +0.00%
OGN logo

OGN · Organon & Co.

Track OGN — free
$13.72 +0.00 (+0.00%) At close · Aug 14
Market Cap
$3.60B
Shares
262.61M
All earnings calls

Earnings call · FY2026 Q1

Organon & Co. Q1 FY2026 Earnings Call

Organon & Co. Q1 FY2026 Earnings Call

Concluded Apr 30, 2026
Apr 30, 2026 0 turns
Period
FY2026 Q1
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $1.46B -3.5% YoY
Diluted EPS $0.55 +66.7% YoY
Gross margin 53.6% -2.0 pp YoY
Net income $146.00M +67.8% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Nexplanon Implanon NXT$201.00M -19% YoY
Other Sundry Established Brands$87.00M +11.5% YoY
Zetia$87.00M +2.4% YoY
Atozet$85.00M +10.4% YoY
Other Non Opiod Pain Bone and Dermatology$68.00M +0% YoY
Hadlima$67.00M +42.6% YoY
Nasonex$65.00M -9.7% YoY
Follistim AQ$61.00M -11.6% YoY

Capital returned

Dividend / share
$0.02
Full-screen source Call document